LMX1A (LIM homeobox transcription factor 1 alpha) is a transcriptional activator that plays crucial roles in neural development and disease pathogenesis. The protein functions as a sequence-specific DNA-binding transcription factor that binds to A/T-rich sequences and activates insulin gene transcription 1. In neural development, LMX1A is essential for dopaminergic neuron specification and ventral midbrain patterning, though forced overexpression can paradoxically induce dorsal neural fates and disrupt proper midbrain dopaminergic neuron development 2. The transcription factor is critical for maintaining adult dopaminergic neurons and shows persistent expression in substantia nigra and ventral tegmental area 3. LMX1A demonstrates tumor suppressor functions in gastric cancer, where it is downregulated and targeted by microRNA-9 for degradation, promoting cancer cell progression 4. The protein is also subject to post-translational regulation through ubiquitination by RNF38, which promotes autophagy and drug resistance in acute myeloid leukemia 5. Genetic variants in LMX1A show associations with obsessive-compulsive disorder symptoms 6 and have been identified as novel risk loci for Alzheimer's disease 7. For therapeutic applications, LMX1A-positive progenitors show promise for Parkinson's disease cell replacement therapy 8.